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cense.Abstract Background: Despite improvements in diagnosis and therapy of oral and oro-pharyn-
geal carcinomas during the past 30 years the 5-year disease-free survival is still poor. Patient’s prog-
nosis is affected by cervical lymph node metastasis rather than primary tumors. The DNA ploidy
and S-phase fraction (SPF) are associated with tumor aggressiveness and patient outcome in many
solid tumors.
Purpose: Analysis of DNA ploidy and SPF in primary oral squamous cell carcinoma (OSCC) and
corresponding node metastasis as prognostic markers in relation to conventional prognostic factors
and disease-free survival (DFS).
Methods: Ploidy status and SPF (mean value) of 37 formalin-ﬁxed parafﬁn embedded (FFPE) pri-
mary OSCC tumors and their corresponding lymph node metastasis were assessed by ﬂow cytom-
etry (FCM) and correlated with clinicopathologic prognostic parameters and DFS.
Results: Most of OSCC tumors (86.5%) were Grade II. Among primary OSCC the incidence of
aneuploidy was 19%, 51.4% showed high SPF (>10.62%) and 48.6% had low SPF
(<10.62%).Border line signiﬁcance (P= 0.10) was detected between ploidy status and SPF in pri-
mary tumors. In lymph node metastases all tumors were diploid, 78.4% of metastatic tumorsm (M.F. El-Deftar).
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8 M.F. El-Deftar et al.revealed low SPF and only 21.6% showed high SPF. There was a statistically signiﬁcant correlation
(p= 0.02) between site of tumors and DFS and a highly statistically signiﬁcant correlation
(p= 0.01) between SPF of primary tumors and DFS.
Conclusions: High SPF of primary OSCC tumors assessed by FCM was signiﬁcantly associated
with decreased disease free survival rates. DNA ploidy showed no relationship to bad prognostic
indicators in either primary OSCC or their metastatic tumors.
ª 2011 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.
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The incidence of oral squamous cell carcinoma remains high
[1]. Oral and oro-pharyngeal carcinomas are the sixth most
common cancer in the world [2]. Despite of all improvements
of diagnosis and therapy the overall survival of patients did
not improve signiﬁcantly with the 5-years survival rates be-
tween 45% and 50% [1].
In Egypt according to National Cancer Institute registry in
2003–2004 oral cavity squamous cell carcinoma constituted
2.45% of total malignancies and 17.06% of all digestive organs
cancer. The tongue was the most common site (36.10%) [3].
The patient’s prognosis varies with tumor size, stage of dis-
ease (TNM), tumor primary site, and the status of surgical
margins. Also the cumulative effects of tobacco, betel nut,
and alcohol decrease the survival rate [4].
Flow cytometry is a laser based technology used to quantify
DNA content of cells and measure the percentage of cells in
each of the different phases of cell cycle. Several studies have
reported that alterations in the DNA content (ploidy) and/or
increase in SPF (as a measure of proliferative activity) were
associated with poor patient’s outcome in a variety of neo-
plasms [5,6].
In most of the researches ﬂow cytometric data of intraoral
squamous cell carcinoma (OSCC) have been lumped with tu-
mors of the head and neck [7–10] due to its lower incidence
rate. However, these results do not necessarily reﬂect the clin-
ical importance of DNA ploidy in site speciﬁc tumors [11].
Moreover, the studies that compared the ploidy status and
SPF of primary OSCC tumors and their lymph node metasta-
sis are very few and no conclusive reports are available on the
DNA pattern of metastatic lymph nodes in this group of
patients.
Objective: To analyze the DNA content and SPF of pri-
mary OSCC tumors and corresponding metastatic nodal le-
sions using ﬂow cytometry and to assess its relationship to
prognosis in comparison to clinicopathological ﬁndings and
DFS.
Patients and methods
The parafﬁn blocks of 37 cases of OSCC surgical specimens
were retrieved from the archives of surgical pathology unit,
Pathology Department, National Cancer Institute, Cairo Uni-
versity between years 2000 and 2007. Only patients with hospi-
tal ﬁles showing full clinical data and complete follow up
ﬁndings as well as sufﬁcient tumor tissue in parafﬁn blocks
from primary tumors and their nodal secondaries were en-
rolled in this study. None of the patients received pre-operative
radiation or chemotherapy. Clinical staging of the tumors was
done according to criteria set by WHO [12].Histopathological examination
Hematoxylin and eosin (H&E) stained sections from the pri-
mary tumors and metastatic lymph nodes were examined to
conﬁrm histopathological diagnosis, assess tumor grade and
to assure that tumor tissue constitutes >70% of the section
with minimal hemorrhagic and necrotic foci. Averages of 10–
15 cervical lymph nodes were examined in each case.
DNA ﬂow cytometry
For DNA analysis single cell suspension from FFPE tumors
was prepared according to a modiﬁed method described by
Hedley [13]. Two to three sections (50 lm thick) were cut from
each block. Sections were deparafﬁnized with xylene and rehy-
drated in graded ethanol followed by two washes in phosphate
buffer saline (PBS 0.1 M, pH 7.4). Each sample was digested
by incubation with pepsin 0.5%, pH 1.5 (Sigma, P6887) at
37 C in water bath for 90 min with intermittent tapping every
5 min for mixing. The disaggregated tissues were ﬁltered
through 50 lm pore size nylon mesh in order to remove debris
and cell clumps that may give abnormal extra peaks during
analysis. After two washes in PBS, trypsin inhibitor, and ribo-
nuclease A (CycleTest PLUS DNA Reagent kit, Cat. No.
340242, Becton–Dickinson, USA) were added to the sample
to stop the action of pepsin and digest RNA. After washing
using PBS the cell count was adjusted to 2–3 · 106 cells/ml.
Nuclear staining for DNA content was done using 50 lg/ml
propidium iodide (PI) (CycleTest PLUS DNA Reagent kit,
Cat. No. 340242, Becton–Dickinson, USA) at room tempera-
ture for 10 min in the dark. The stained samples were acquired
by ﬂow cytometer (Facscan, Becton–Dickinson (B–D) Sunny-
vale, CA). Calibration of the ﬂow cytometer was done using PI
labeled chicken RBC’s. Normal human peripheral blood lym-
phocytes were used to identify the normal diploid peak that
served as reference peak for subsequent analysis. From each
sample at least 10,000 cells were acquired by ﬂow cytometer
at a rate of 100–200 cells/s and data were presented as DNA
distribution histograms. Data were analyzed using Modﬁt soft-
ware (Becton–Dickinson (B–D) Sunnyvale, CA). Interpreta-
tion of DNA histograms was done according to Das et al.
[14] and Baretton et al. [15]. Histograms showing a single
G0/G1 peak were deﬁned as diploid. Tumors that exhibit
two distinct histogram G0/G1 peaks (second peak is >10%
away from diploid one) were classiﬁed as aneuploid. The
DNA index (DI) was obtained by calculating the ratio of mean
channel number of abnormal aneuploid G0/G1 peak to the
mean channel number of the normal (diploid) G0/G1 peak.
Table 1 shows the ﬁve arbitrary DI classes that were used
for further classiﬁcation of aneuploid tumors [16]. The mean
co-efﬁcient of variation (CV) of the measurement recorded
Prognostic signiﬁcance of ploidy and S-phase fraction 9by ﬂow cytometer ranged from 5% to 8%. Cut-off of the SPF
was determined by calculating mean SPF values.
Statistical analysis
The study data were summarized as frequency and percentage
(qualitative data) or as mean ± standard deviation (SD)
(numerical data). Data were analyzed using SPSS win statisti-
cal package version 12. Chi-square test (Fisher’s test) was used
to examine relationship between qualitative variables while for
quantitative data Mann–Whitney test was used for variables
not normally distributed. Survival analysis was done using
Kaplan–Meier method. Comparison between two survival
curves was performed using log rank test. P value 60.05 was
considered as statistically signiﬁcant.
Results
Clinical and histopathological ﬁndings
The patient population comprised 21 males (56.8%) and 16 fe-
males (43.2%). Their mean age at ﬁrst diagnosis was 52.5 years
(min. 29 years and max. 75). Primary sites were mainly identi-
ﬁed in the tongue (51.4%), buccal mucosa (21.6%), retromolar
gingiva (18.9%), and ﬂoor of mouth (8.1%). According to
TNM classiﬁcation, 37.8% of OSCC patients had Stage III tu-
mors while 62.2% were Stage IV. Most of patients (86.5%)
had moderately differentiated tumors (Grade II) while Grade
III and Grade I comprised 8.1% and 5.4%, respectively.
Disease free survival (DFS) status
The follow up period ranged from 3 to 24 months with a med-
ian of 6 ± 0.2 months. At the end of follow up, 21.6% of SCC
cases revealed no recurrence, 54.1% of cases showed local
recurrence, 18.9% showed distant metastasis. Two cases
(5.4%) exhibited both local recurrence and distant metastasis.
Five patients died from disease after local recurrence or distant
metastasis (Fig. 1).
Flow cytometric ﬁndings
Primary OSCC tumors
Among 37 OSCC tumors analyzed, 30 tumors (81%) were dip-
loid. Seven primary OSCC tumors were aneuploid (19%) and
were further classiﬁed into six hyperdiploid tumors
(DI = 1.32–1.87, mean of 1.71) and one tetraploid tumor
(DI = 1.93) (Fig. 2). Nineteen out of 37 (51.4%) tumors had
high SPF (number of cells in SPF >10.63%) while 18 out of
37 cases (48.6%) had low SPF (number of cells <10.63%).Table 1 DNA index (DI) intervals used for analysis of OSCC.
Ploidy DNA index (DI)
Hypodiploid DI < 0.95
Diploid 0.95 6 DI < 1.05
Hyperdiploid 1.05 6 DI < 1.90
Tetraploida 1.90 6 DI < 2.10
Hypertetraploid DIP 2.10
a Tetraploidy: proportion of the G2M cells of diploid population
exceeds 15%.The SPF ranged from 1.24% to 43.66% with a mean of
10.63%± 3.96. Border line signiﬁcant relationship
(P= 0.10) was detected between ploidy status and SPF.
Among the 30 diploid tumors, 14 tumors (46.7%) had high
SPF (mean 22.3%) while 16 (53.3%) of cases revealed low
SPF (mean 9.12%). On the other hand most of aneuploid tu-
mors (71.4%) showed high SPF (mean 22.65%) and only two
tumors revealed low SPF (mean 5.58%) (Table 2).
Metastatic lymph nodes
In lymph node metastases all tumors were diploid. Regarding
SPF 78.4% (29/37) of metastatic tumors revealed low SPF and
21.6% showed high SPF. The SPF ranged from 1.24% to
23.58% (Fig. 3).
Correlation between ﬂow cytometric parameters
and clinicopathological ﬁndings
None of the clinical variables (patient age, gender, tumor site,
histopathological grade, and stage) compared to ploidy status
or SPF was of statistical signiﬁcance in either primary tumors
or metastatic LN tumors. Borderline signiﬁcance (P= 0.10)
was found on relating patient sex with SPF of primary tumors.
Most of the females had low SPF (62.5%) while most of the
males (61.9%) have high SPF (Table 3).
Disease free survival analysis
Disease free survival of OSCC patients reached 27.03% at
6 months. Female patients exhibited higher DFS (31.3%) at
6 month than males (23.8%) but relationship was not statisti-
cally signiﬁcant (p= 0.51). Regarding the site, patients were
classiﬁed into those with tongue tumors and those with tumors
in all other sites. A statistically signiﬁcant correlation
(p= 0.02) was noticed between site of tumors and DFS. At
6 months DFS was 10.5% in tongue tumors while it was
44.4% in tumors of other sites (Fig. 4). No statistically signiﬁ-
cant relationship was observed between histopathological
grade and DFS. Border line signiﬁcance (p= 0.10) was noticed
on relating DFS with tumor stage. DFS at 6 months for Stage
III tumors was 38.9% while for Stage IV cases it was 15.8%
(Fig. 5). When the SPF was divided into high (>10.63%)
and low (<10.63%) groups, a highly statistically signiﬁcant
correlation was found between SPF of primary tumors and
DFS (p= 0.01). DFS at 6 months was 44.4% in cases withFigure 1 Disease free survival status of OSCC patients (NR, no
recurrence; LR, local recurrence; Met., metastasis; R+ Met.,
recurrence and metastasis).
Figure 2 DNA ploidy pattern of primary OSCC tumors, (A) diploid tumor with low SPF (3.01%), (B) diploid tumor with high SPF
(11.70%), (C) aneuploid (near diploid) pattern with low SPF (4.93%), (D) tetraploid (G2M= 32.47%) aneuploid tumor with high SPF
(12.39%).
Table 2 Relationship between ploidy and SPF in primary
OSCC tumors.
Tumor Ploidy P value
Diploid Aneuploid
Primary OSCC 30 (81%) 7 (19%)
SPF* (10.63%± 3.96%)
High (>10.63) 14 (46.7%) 5 (71.4%) 0.10**
Low (<10.63) 16 (53.3%) 2 (28.6%)
* SPF (mean ± SD).
** Border line signiﬁcance.
10 M.F. El-Deftar et al.low SPF versus 10.5% of tumors with high SPF (Fig. 6).
Although patients with aneuploid primary tumors fared worse
than diploid ones as regard DFS (14.2% versus 30%) however
the correlation was not of statistical signiﬁcance.
Discussion
Oral cancer is often discovered when cancer has metastasized
to another location most likely lymph nodes of the neck.
Prognosis at this stage of discovery is signiﬁcantly worse than
localized intraoral disease [17].
There are several types of oral cancers but about 90% are
squamous cell carcinoma. In addition to poor histologic differ-
entiation, presence of metastatic lymph nodes has often been
reported as the single most important prognostic factor in pa-tients with OSCC [18]. Association of DNA pattern of primary
tumors as well as their metastatic nodes with disease free sur-
vival is still controversial.
In the present research around half of OSCC tumors were
located in the tongue (51.4%), followed by buccal mucosa
(21.6%). Sargeran et al. [19] reported that the most common
oral cancer site was the tongue accounting for 50% of oral
cavity cancer. Out of 19 tongue squamous cell carcinoma 14
patients were less than 60 years. This was emphasized by other
authors who stated that tongue squamous cell carcinoma
constitute a large percent of head and neck cancers, and the
incidence among young patients is increasing [20].
Nineteen percent of the analyzed primary OSCC tumors
were aneuploid. A higher incidence of aneuploidy among
OSCC tumors was reported by western researchers (30–58%)
[14,21,22]. The discrepancy can be explained by dominance
of Grade II OSCC tumors in our study (86.5%) while Grade
III and Grade I comprised only 8.1% and 5.4%, respectively.
In agreement with our results, some researchers showed that
the incidence of aneuploidy among their series of OSCC Grade
II tumors was 20% [22] and 15.43% [23].
It was generally observed that the researchers who used
OSCC fresh tissues reported a higher incidence of aneuploidy;
58% [24] than those who used FFPE OSCC samples; 30% [21],
39% [22], and 41% [23]. Furthermore, authors observed that
DNA ploidy is heterogeneous within squamous cell carcinoma
of the oral cavity and the incidence of aneuploidy was very
high when multiple tissue samples from each tumor were ana-
lyzed [15].
Figure 3 DNA ploidy proﬁle of lymph node metastatic deposits of OSCC tumors, (A) diploid tumor with low SPF (3.58%), (B) diploid
tumor with high SPF (12.14%).
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OSCC tumors was aneuploid. Discrepancy between ploidy sta-
tus in primary OSCC tumors and their corresponding lymph
node metastasis was reported by other investigators who ana-
lyzed ploidy status and SPF of 96 FFPE primary OSCC
tumors and their 85 metastatic nodal tumors [22]. They men-
tioned that shift down to diploidy was observed in 25 out of
39 metastatic lymph nodes associated with aneuploid primaryTable 3 Clinicopathological parameters and FCM ﬁndings of prim
Variables SPF
Low Hig
Age <40 2 5
28.6% 71.4
40–60 6 17
26% 74%
>60 3 4
43% 57%
Sex Male 8 13
38.1% 61.9
Female 10 6
62.5% 37.5
Site Tongue 6 13
31.6% 68.4
Retromolar area and gingiva 2 5
28.6% 71.4
Buccal mucosa 2 6
25% 75%
Mouth ﬂoor 0 3
0% 100%
Grade I 0 2
0% 100%
II 11 21
44.4% 65.6
III 0 3
0% 100%
Stage III 5 12
43.4% 66.6
IV 6 13
31.6% 68.4
* NS, not signiﬁcant.
** BS, borderline signiﬁcance.tumors. One possible explanation is that the diploid cells
rather than aneuploid ones are responsible for causing lymph
node metastasis; however they gradually change into aneu-
ploid cells during the process of progression in the metastatic
site as they do at the primary sites.
After revising the H&E sections of metastatic LN again we
noticed that even if metastatic tumor cells heavily affected
most of the lymph node(s) area yet the existence of someary OSCC tumors.
p-Value Ploidy state p-Value
h Diploid Aneuploid
6 1
% 85.7% 14.3%
0.30 19 4 0.35
NS* 82.6% 17.4% NS
5 2
71.5% 28.5%
16 5
% 0.10 76.2% 23.8% 0.89
BS** 14 2 NS
% 87.5% 12.5%
16 3
% 84.2% 15.8%
0.87 6 1 0.85
% NS 83.3% 16.7% NS
6 2
75% 25%
2 1
66.7% 33.3%
2 0
0.18 100% 0% 0.78
NS 26 6 NS
% 81.3% 18.8%
2 1
66.7% 33.3%
14 4
% 0.86 77.8% 22.2% 0.58
NS 16 3 NS
% 84.2% 15.8%
Figure 4 Disease free-survival in relation to OSCC site (p= 0.025).
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Figure 5 Disease free-survival in relation to tumor stage among 37 OSCC patients (p= 0.118).
12 M.F. El-Deftar et al.reactive lymphoid elements or even one or two reactive lymph
nodes on the same section was inevitable. From the technical
point the presence of signiﬁcant number of non-tumorous cells
in the sample may hide small aneuploid populations of cells
especially in FFPE with wide CV. Microdissection of
metastatic tumor cells from the lymph nodes may overcome
this problem by enriching the analyzed samples with tumor
cells and minimizing the fraction of normal and/or reactive
lymphocytes during ﬂow cytometric analysis especially if tu-
mor cells are widely separated.
In contrast to DNA ploidy analysis, investigators suggested
that determination of SPF from one randomly chosen biopsy
specimen is representative of the proliferative activity of the
carcinoma, because intratumoral SPF variation is low [25].
Our study showed that the mean SPF was lower in meta-
static lymph nodes (6.58 ± 1.32%) than that in primarytumors (10.63 ± 3.96%). Concordant results were shown by
other investigators who reported a lower mean SPF of lymph
node metastasis (6.96%) than that of primary OSCC tumors
(11.24%) [14].
Border line signiﬁcant relationship (p= 0.10) was detected
between DNA ploidy and SPF of the primary OSCC tumors.
The results revealed that 71.4% of the aneuploid tumors versus
46.7% of the diploid tumors had high SPF. Several authors
reported, that the SPF was signiﬁcantly higher in aneuploid
OSCC tumors than in diploid carcinomas [14,16,24].
No signiﬁcant association was found between DNA ploidy
of either primary or metastatic tumors with age, sex, tumor
site, histopathologic grade, and tumor stage.
The relationship between clinicopathological variables and
DNA ploidy in OSCC is frequently debated. Some authors in
accordance to our results did not identify an association
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Figure 6 Disease free-survival in relation to SPF of primary OSCC tumors (p= 0.017).
Prognostic signiﬁcance of ploidy and S-phase fraction 13between them [14,26] while others did. Investigators reported
that aneuploid tumors were signiﬁcantly more likely to be
found in men and to have poor differentiation and advanced
stage (III, IV) [27].
A signiﬁcant correlation was found between the DFS and
tumor site (p= 0.02) as local recurrence and distant metastasis
were detected in 61% (13/21) and 55.5% (5/9), respectively, of
tongue tumors rather than lesions in other sites in oral cavity.
These ﬁndings were in agreement with the studies of many
researchers who concluded that tongue SCC was associated
with poor survival compared with other oral cavity and head
and neck sites [28–30]. The clinical stage revealed a border line
signiﬁcance (p= 0.10) in relation to DFS.
A highly statistically signiﬁcant correlation (p= 0.01) was
detected between SPF of primary tumors and DFS. While
the correlation did not reach the level of statistical signiﬁcance
(p= 0.35) in metastatic lymph node tumors.
Russo et al. [31] revealed that among 36 patients with lo-
cally advanced squamous cell carcinoma, the major signiﬁcant
predictor of both disease relapse and death was high SPF and
TP53 mutation. Hass et al. [32] performed ﬂow cytometric
analysis of 48 primary and recurrent head and neck squamous
cell carcinoma tumors. Their ﬁndings indicated that prolifera-
tive activity was signiﬁcantly associated with malignant
progression and recurrence.
Although patients with aneuploid primary tumors fared
worse than diploid ones as regard DFS (14.2% versus 30%)
however their relationship was not statistically signiﬁcant.
Comparable results were reported by other authors [32,26].
Conclusion
High SPF of primary OSCC tumors assessed by FCM was
signiﬁcantly associated with decrease disease free survival
rates. DNA ploidy showed no relationship to bad prognostic
indicators in either primary OSCC or their metastatic
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